SimBioSys, Inc.

We’re honored to be recognized as a key healthcare AI partner by Kimberly Powell from NVIDIA at the 2024 HLTH Conference in Las Vegas, happening from October 20th to 23rd. If you’re attending the conference, we’d love to connect—just send us a DM! If you’re not attending but still want to chat, feel free to reach out as well! #HLTH2024, #NVIDIA, #AI, #Precisionmedicine, #Breastcancer, #Oncology

Breast Cancer Awareness Month: The Power of Early Detection and Precision Surgery October is a time to raise awareness about the importance of early detection in the fight against breast cancer. Early diagnosis saves lives and opens up more treatment options for patients facing critical treatment decisions. At SimBioSys, we're proud to support surgeons with the insights they need to make informed, personalized decisions that benefit their patients most with tools like TumorSight Viz. TumorSight Viz equips surgeons with the data they need to confidently plan less invasive, breast-conserving procedures. Let’s continue raising awareness and advocating for technologies that enhance early detection and offer precise, life-changing treatments for breast cancer. #BreastCancerAwareness #EarlyDetection #BreastConservation #LessInvasiveSurgery #TumorSight #PrecisionMedicine #WomensHealth #SurgicalInnovation #BreastCancerCare

SimBioSys, Inc. applauds the Senate introduction of the bipartisan Find it Early Act which would require Medicare and private payers to cover supplemental imaging for women with dense breasts. We're deeply committed to the fight to personalize breast cancer care. Our revolutionary TumorSight® technology harnesses AI and spatial biophysics to provide surgeons with enhanced visualization and findings unique to each patient's tumor. We're on a mission to unlock a deeper understanding of cancer, empowering more precise and personalized treatments for every patient. #EarlyDetection #WomensHealth #PrecisionMedicine https://lnkd.in/eeFHbXP2

Mercy Medical Center and The Hall-Perrine Cancer Center Gaining Value from Utilizing TumorSight Viz! We’re thrilled to share that Mercy Medical Center is revolutionizing breast cancer surgeries in Cedar Rapids with TumorSight Viz, providing patients with the most advanced, personalized care available. This partnership represents a major leap in surgical precision for Mercy’s patients, utilizing advanced AI and 3D imaging for enhanced visualization. TumorSight Viz provides detailed 3D visualizations that map the tumor’s exact location, volume, and surrounding anatomy. With these crucial insights, breast surgeons can plan and execute surgeries with greater accuracy, enabling them to explore less invasive approaches. A special thanks to Vincent Reid, MD, FACS and the incredible team at Mercy for their commitment to bringing innovative solutions to patient care. We’re proud to collaborate with such forward-thinking physicians and excited for the positive impact TumorSight Viz will have on breast cancer treatment in Iowa. Check out the full article to learn more: https://lnkd.in/gx3BYdnS #HealthcareInnovation #BreastCancerTreatment #AIinHealthcare #SimBioSys #TumorSight #MercyMedicalCenter #SurgicalExcellence #PatientCare 

We are proud to partner with the innovative Mayo Clinic in Digital Health 😀 Thank you for the recognition Galen Growth | Insights You Can Trust 🙏 #AI #Digitalhealth #Precisionmedicine #Breastcancer #oncology

SimBioSys celebrates a great day for women’s health—a day when information and early detection take center stage in the battle against breast cancer! To learn more about this exciting new legislation, please read further! #WomensHealth #BreastCancerAwareness #EarlyDetection #DenseBreastLaw #BreastHealth #CancerScreening #HealthcareInnovation #BreastCancerPrevention #SimBioSys

✨ Empowering Patients with Modern Technology ✨ Dr. Allison DiPasquale at Texas Oncology recently shared invaluable advice for breast cancer patients, highlighting modern technology’s role in de-escalating unnecessary care and empowering patients to make informed treatment decisions with their oncology team. Dr. DiPasquale specifically stresses the importance of discussing these options with your medical team, as modern technology enables personalized treatments that can reduce the need for extensive surgery and chemotherapy. TumorSight Viz is one such technology that is changing the game in the breast cancer surgery space. Our advanced AI-powered technology provides surgeons with unparalleled visualization and insights, allowing for more informed surgical decision-making.  Let's spread the word about the power of technology in transforming breast cancer treatment. Together, we can make a difference. 💪  #BreastCancerAwareness #ModernMedicine #TumorSightViz #PatientCare #DeescalateTreatment https://lnkd.in/gSU4Gw4Q

We are thrilled to announce a groundbreaking publication by our co-founder and Chief Scientific Officer, John Cole. His work on predictive modeling in oncology highlights innovative approaches to revolutionize cancer treatment and patient care. Key Highlights: • Predicting treatment outcomes • Integrating multi-omics data • Enhancing personalized treatment plans This publication showcases our commitment to advancing precision medicine through cutting-edge computational modeling. Congrats to John and the team for this remarkable achievement! #SimBioSys #Oncology #PrecisionMedicine #Research #Innovation #Healthcare

Congratulations to SimBioSys, Inc. scientists Jesse Bucksot, PhD, Katherine Ritchie, John C., and Daniel Cook for their groundbreaking work defining metabolic hallmarks across 34 cancer types, identified in 10,915 patients! The method, published in Cancers MDPI, provides biological interpretability to metabolic biomarkers, answering questions such as: • How does the growth rate of this tumor compare to those from other patients with the same cancer type? • What metabolic pathways deviate from expected values based on a large cohort of patients? • Are those pathways druggable? Read more here: https://lnkd.in/gGibTiZ8 #CancerResearch #HallmarksOfCancer #MetabolicModeling #PrecisionMedicine

We're excited to announce that our CEO and Co-Founder, Tushar Pandey, was recently featured on the LifeScience Success Podcast with Don Davis PhD, MBA Davis, PhD, MBA! In this episode, Tushar delves into the cutting-edge world of digital precision medicine in oncology and more: 🤖 The Power of AI: Discover how we're leveraging artificial intelligence to revolutionize cancer treatment. 💡 SimBioSys Innovation: Learn about the groundbreaking technology driving our mission to transform oncology. 🔮 Vision for the Future: Explore what's next for digital precision medicine and the biotech industry. 🌍 Act Local, Think Global: From Uganda to the USA, hear about Tushar's inspiring journey and its impact on SimBioSys’s commitment to ensuring healthcare equity for all. At @SimBioSys, we harness the power of AI and biophysical modeling to deliver personalized cancer treatment solutions. We extend our heartfelt thanks to Don Davis and the Life Science Success Podcast for featuring SimBioSys, allowing us to share our vision and the impact we're making in oncology. If you're interested in learning more, please have a listen! https://lnkd.in/giDijCAq #Simbiosys #Biotech #Innovation #AIinBiotech #DigitalPrecisionMedicine #Oncology #BiotechStartups #SciencePodcast #LifeScienceSuccess